As a wave of new migraine drugs begin to hit the market, some scientists are questioning ...

Last year erenumbab was approved by the FDA, the first in an entirely new class of drugs designed to help migraine sufferers to reach the general public. A study is now reporting successful Phase 3 clinical trial results for a new orally administered iteration in this class of drugs, ahead of a potential FDA approval later this year. But some scientists are beginning to question how clinically useful these new migraine drugs actually are.

Continue Reading Questions raised over efficacy of cutting-edge new migraine drugs

Category: Medical